Author

Anbu Liu

Institution: Ningxia Medical University

Observed institution: Ningxia Medical University

OpenAlex ID: A5083257043

DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors

2023 · Anbu Liu, Shaoting Zhang, et al. · Molecular Carcinogenesis · 8

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib

2023 · Shujing Li, Sien Zhao, et al. · Gastric Cancer · 8

Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling

2024 · Shaoting Zhang, Liangying Zhang, et al. · Molecular Carcinogenesis · 4

Farnesyltransferase (FTase) Inhibitors Increase Inhibition of KIT Mutants by Imatinib

2023 · Zhaoyang Fan, Liangying Zhang, et al. · Reports of Biochemistry and Molecular Biology

[D816V mutation of KIT specifically induces phosphorylation of HNRNPL and HNRNPK in COS-1 cells].

2023 · Liangying Zhang, Shaoting Zhang, et al. · PubMed

Works count: 5

Citation count: 20

H-index: 3

I10-index: